Herbert K.

Keller, TX

Herbert Shares His Stem Cell Treatment for His COPD

Age: 69  |  Location: Keller, TX  |  Condition: COPD

Herbert K. has COPD and used to enjoy doing yardwork and chores. Shortness of breath and 15 percent lung capacity made him unable to do simple tasks, leaving him feeling depressed. Herbert’s wife, Barbara, had a hard time watching her husband suffer and feared that he may not live much longer. After hearing about the Lung Institute, they decided to try treatment.

Two months after his initial treatment, Herbert had a pulmonary function test, which showed his lung capacity had increased to 31 percent. His lung capacity has continued to improve after a booster treatment, and now it’s at 47 percent. Herbert and Barbara are pleased with his success.

Herbert says, “When you’re used to doing things and then they’re taken away from you, it’s hard to understand how it affects you mentally and how good it feels to do those simple things again.”

If you or someone you love has COPD, pulmonary fibrosis or another chronic lung disease and would like to see improvements like Herbert’s, contact us at (800) 729-3065 to learn more about stem cell treatment options.

Are you a candidate? Call (800) 729-3065 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Jerry E.
Kernersville, NC
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Thomas V.
Keene, NH
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.